Bristol Myers Squibb (CELG-RI) Tax Rate (QoQ) (2009 - 2026)

Bristol Myers Squibb (CELG-RI) Tax Rate (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -881.00
Dec 31, 2025 -339.00
Sep 30, 2025 357.00
Jun 30, 2025 881.00
Mar 31, 2025 -3,944.00
Dec 31, 2024 2,907.00
Sep 30, 2024 5,845.00
Jun 30, 2024 -2,754.00
Mar 31, 2024 185.00
Dec 31, 2023 -1,476.00
Sep 30, 2023 2,123.00
Jun 30, 2023 -2,989.00
Mar 31, 2023 2,709.00
Dec 31, 2022 -3,614.00
Sep 30, 2022 19.00
Jun 30, 2022 307.00
Mar 31, 2022 5,161.00
Dec 31, 2021 -5,571.00
Sep 30, 2021 -363.00
Jun 30, 2021 1,188.00